Search Results - "Frye, Sarah"

Refine Results
  1. 1

    Ancillary Finding on Myocardial Perfusion Imaging Due to Urinary Bladder Displacement by Frye, Sarah A, Bajric, Ejda, Slavin, Avril

    Published in Journal of nuclear medicine technology (01-06-2022)
    “…When imaging patients are referred for single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) with technetium 99m ( Tc) agents,…”
    Get full text
    Journal Article
  2. 2

    SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer-Regulatory Process, Part I: How and When Radiopharmaceuticals Can Be Used by Jeffers, Charlotte Denise, Frye, Sarah A, Hoffman, John M

    Published in Journal of nuclear medicine technology (01-03-2022)
    “…For CE credit, you can access the test for this article, as well as additional CE tests, online at https://www.snmmilearningcenter.org Complete the test online…”
    Get full text
    Journal Article
  3. 3

    Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis by Vittal, Ragini, Mickler, Elizabeth A, Fisher, Amanda J, Zhang, Chen, Rothhaar, Katia, Gu, Hongmei, Brown, Krista M, Emtiazjoo, Amir, Lott, Jeremy M, Frye, Sarah B, Smith, Gerald N, Sandusky, George E, Cummings, Oscar W, Wilkes, David S

    Published in PloS one (21-10-2013)
    “…Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by progressive scarring and matrix deposition. Recent reports highlight…”
    Get full text
    Journal Article
  4. 4

    SNMMI Clinical Trial Network Research Series for Technologists: Application of Good Clinical Practice to Clinical Research in Medical Imaging by Trembath, LisaAnn, Frye, Sarah A, Scott, Peter J H, Hoffman, John M

    Published in Journal of nuclear medicine technology (01-03-2023)
    “…This article is part of a series developed by the Clinical Trials Network of the Society of Nuclear Medicine and Molecular Imaging to offer training and…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Multi-modal Pain Control Protocol Decreases Narcotic Consumption in an Inpatient Trauma Population by Biester, Joel M L, Mentzer, Caleb J, Caswell, Shayne R, Morrow, Charles E, Mount, Micheal G, Thurston, Brian C, Compton, Bari S, Bendyk, Heather A, Frye, Sarah W, Mohorn, Phillip L, Lombardozzi, Kristine A

    Published in The American surgeon (01-05-2022)
    “…Opioid use after surgery or trauma has been implicated as a contributing factor to opioid dependence. The Acute Care Surgery (ACS) service at our…”
    Get more information
    Journal Article
  7. 7

    Association Between Altered Hip Extension and Kinetic Gait Variables by Wonsetler, Elizabeth C, Miller, Ellie L, Huey, Katherine L, Frye, Sarah E, Bowden, Mark G

    “…ABSTRACTKinematic and kinetic outcome measures are tightly linked in walking. Although altering motor output is a major goal of gait rehabilitation, little is…”
    Get full text
    Journal Article
  8. 8

    Novel Method to Detect and Characterize 18 F-FDG Infiltration at the Injection Site: A Single-Institution Experience by Muzaffar, Razi, Frye, Sarah A, McMunn, Anna, Ryan, Kelley, Lattanze, Ron, Osman, Medhat M

    Published in Journal of nuclear medicine technology (01-12-2017)
    “…A novel quality control and quality assurance device provides time-activity curves that can identify and characterize PET/CT radiotracer infiltration at the…”
    Get full text
    Journal Article
  9. 9

    First-in-Man Evaluation of I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment by Richard Laforest PhD, Farrokh Dehdashti MD, Yongjian Liu PhD, Jennifer Frye CMMT, Sarah Frye CMMT, Hannah Luehmann, Deborah Sultan, Joseph S. Shan PhD, Bruce D. Freimark PhD, Barry A. Siegel MD

    Published in Molecular imaging (09-10-2017)
    “…Purpose: PGN650 is a F(ab′) 2 antibody fragment that targets phosphatidylserine (PS), a marker normally absent that becomes exposed on tumor cells and tumor…”
    Get full text
    Journal Article
  10. 10

    Usefulness of Topically Applied Sensors to Assess the Quality of 18F-FDG Injections and Validation Against Dynamic Positron Emission Tomography (PET) Images by Lattanze, Ronald K, Osman, Medhat M, Ryan, Kelley A, Frye, Sarah, Townsend, David W

    Published in Frontiers in medicine (01-11-2018)
    “…Infiltrations of 18F-fluorodeoxyglucose (FDG) injections affect positron emission tomography/computed tomography (PET/CT) image quality and quantification. A…”
    Get full text
    Journal Article
  11. 11

    Review of HIPAA, Part 1: History, Protected Health Information, and Privacy and Security Rules by Moore, Wilnellys, Frye, Sarah

    Published in Journal of nuclear medicine technology (01-12-2019)
    “…The Health Insurance Portability and Accountability Act (HIPAA) of 1996 has made an impact on the operation of health-care organizations. HIPAA includes 5…”
    Get full text
    Journal Article
  12. 12

    Interview with Nuclear Medicine Technology Educators on the Impact of COVID-19 on Programs, Outcomes, and Employers by Frye, Sarah, Prekeges, Jennifer

    Published in Journal of nuclear medicine technology (01-06-2022)
    “…Coronavirus disease 2019 (COVID-19) has influenced changes at health-care facilities. The editors of Journal of Nuclear Medicine Technology were interested in…”
    Get full text
    Journal Article
  13. 13

    Review of HIPAA, Part 2: Limitations, Rights, Violations, and Role for the Imaging Technologist by Moore, Wilnellys, Frye, Sarah

    Published in Journal of nuclear medicine technology (01-03-2020)
    “…This article is the second part of a continuing education series reviewing the Health Insurance Portability and Accountability Act (HIPAA) of 1996. The term…”
    Get full text
    Journal Article
  14. 14

    Quality Workplace Practices in Nuclear Medicine Enable Superior Patient Care by Frye, Sarah

    Published 01-01-2023
    “…These articles bring awareness to imaging technologists on their role in clinical care; individual patients have the right to effective equipment, radiation…”
    Get full text
    Dissertation
  15. 15

    A photopenic circular artifact that resulted in a gamma camera head rebuild: A technologist case study by Frye, Ross, Frye, Sarah, Osman, Medhat

    Published in The Journal of nuclear medicine (1978) (01-05-2017)
    “…Objectives: A photopenic circular artifact and increasing integral uniformity values on daily quality control on a gamma camera detector caused our department…”
    Get full text
    Journal Article
  16. 16

    Examining Ultratrace Iobenguage I-131 for use in Patients with Malignant Pheochromocytoma/Paraganglioma or Metastatic Carcinoid by Abdullaeva, Sabrina, Botkin, Crystal, Frye, Sarah, Muzaffar, Razi, Osman, Medhat

    Published in The Journal of nuclear medicine (1978) (01-05-2019)
    “…Objectives: Azedra (iobenguane I-131) is the first and only FDA-approved therapeutic drug to treat patients with unresectable, locally advanced, or metastatic…”
    Get full text
    Journal Article
  17. 17

    Evaluation of digital PET imaging Vereos PET/CT by Jaime, Maria, Botkin, Crystal, Frye, Sarah, Muzaffar, Razi, Osman, Medhat

    Published in The Journal of nuclear medicine (1978) (01-05-2019)
    “…Objectives: Technology and diagnostic innovations are continuously advancing in medical imaging. Limitations arise in the standard analog system of standard…”
    Get full text
    Journal Article
  18. 18

    SNMMI Clinical Trials Network Research Series for Technologists: Ethical Issues and Regulations in the Medical Workplace by Frye, Sarah, Butterfield, Regan, Hoffman, John M

    Published in Journal of nuclear medicine technology (01-12-2021)
    “…Ethical principles and laws have developed as medical practice and research have grown. This article discusses regulatory policies in patient care and the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Challenges and practicalities in the clinical implementation of Lutetium 177 for therapeutic nuclear medicine: a technologist’s perspective by Warhoover, Ryan, Frye, Sarah, Frye, Ross, Osman, Medhat, Sterkel, Barbara

    Published in The Journal of nuclear medicine (1978) (01-05-2018)
    “…Objectives: FDA approval of Lutetium177 (Lu177) treatment of neuroendocrine tumor is pending. Lu177 therapy is logistically different than any other currently…”
    Get full text
    Journal Article